Condition
Haemodynamic Rebound
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (2)
P 4 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06490731Phase 1RecruitingPrimary
Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients
NCT02139631Not ApplicableCompletedPrimary
Hemodynamic Repercussions of Noninvasive Ventilation
NCT02271555Phase 4UnknownPrimary
The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy
NCT01611181Phase 1CompletedPrimary
Iron Substitution After Total Knee Arthroplasty
Showing all 4 trials